GANX vs. SEER

In the year-to-date period, GANX achieves a -13.89% return, which is significantly lower than SEER's -8.66% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Gain Therapeutics, Inc. (GANX) and Seer, Inc. (SEER). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GANX Sharpe Ratio is -0.19, which is lower than the SEER Sharpe Ratio of -0.05. The chart below compares the historical Sharpe Ratios of GANX and SEER, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither GANX nor SEER has paid dividends to shareholders.

The maximum GANX drawdown since its inception was -94.08%, roughly equal to the maximum SEER drawdown of -98.25%. Use the drawdown chart below to compare losses from any high point for GANX and SEER. For additional features, visit the drawdowns tool.

Gain Therapeutics, Inc. (GANX) has a higher volatility of 19.13% compared to Seer, Inc. (SEER) at 16.19%. This indicates that GANX's price experiences larger fluctuations and is considered to be riskier than SEER based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Gain Therapeutics, Inc. and Seer, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.